CDx Diagnostics‘ parent company has raised more than $11 million in its latest money-raise as it continues to promote its WATS3D diagnostic platform for spotting pre-cancerous cells in the esophagus. Six investors provided money to CDx Medical Holdings, according to the SEC Form D dated Dec. 16. The company had sought up to $17.3 million. […]